Summary

Overview
Global Minimally Invasive Surgery Devices market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031.
Minimally invasive surgery (MIS) devices are specialized tools and instruments used by surgeons to perform a wide variety of surgical procedures through small incisions or natural body openings.
Minimally invasive surgery procedures are increasingly adopting a variety of MIS devices. High-resolution, magnified views of the surgery site are provided by MIS instruments such as endoscopes. Better identification of anatomical features and increased precision during sensitive treatments are made possible by using MIS devices.
Market Dynamics: Drivers & Restraints
Increasing launches of advanced minimally invasive surgery devices
The increasing number of launches of advanced minimally invasive surgery devices and increasing demand for the procedures are expected to drive the market growth. The increasing advanced technological device launches increase interest of the physicians and make them used in a variety of procedures.
For instance, in October 2023, joimax launched its new iLESSYS Biportal Interlaminar Endoscopic Surgical System for the treatment of spinal disorders at the EUROSPINE 2023 Annual Meeting in Frankfurt and at the SMISS Annual Forum (Society for Minimally Invasive Spine Surgery) in Las Vegas, marking its global debut.
Additionally, in September 2022, Olympus Corporation (Olympus) released the THUNDERBEAT Open Fine Jaw Type X surgical energy devices for open surgery. With a new thermal shield, the THUNDERBEAT Open Fine Jaw Type X surgical energy device is designed to support safer procedures. Thus, the above factors are expected to drive market growth in the forecast period.
High costs of minimally invasive surgery devices
High cost of the devices is expected to hinder the market growth. Highly advanced MIS devices can be expensive due to factors like complex technology, intricate manufacturing processes, and ongoing research & development. This high initial investment cost can limit hospital budgets from buying these devices. Thus, the high cost of the devices can hamper the market growth.
For more details on this report ? Request for Sample
Segment Analysis
The global minimally invasive surgery devices market is segmented based on device type, application, end-user and region.
Endoscopes segment is expected to dominate the market growth
The endoscopes segment is expected to hold a dominant position in the market share during the forecast period. The increasing endoscopy procedure is increasing the demand for endoscopes. Endoscopy is a minimally invasive, nonsurgical procedure used to examine a person’s digestive tract, an internal organ, or other tissue in detail.
The procedure employs an endoscope, a flexible fiber-optic tube with a tiny TV camera at the end. The camera is connected to an eyepiece for direct viewing that displays the images on a color TV. The endoscope allows for the effective diagnosis of gastrointestinal (GI) disease.
For instance, according to the report by the National Institute of Health, it is estimated that more than 20 million GI endoscopies are performed yearly in the United States. Thus, the above factors are expected to drive the market growth.
Geographical Analysis
North America is expected to hold a significant position in the minimally invasive surgery devices market share
North America is expected to hold the dominant position in the market share during the forecast period. The increased number of launches of advanced devices, increasing technology and increased demand for minimally invasive surgical procedures are expected to hold the region in the dominant position.
For instance, in December 2022, Abbott launched its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor, making the minimally invasive device available for people in India with severe aortic stenosis who are at high or extreme surgical risk.
Additionally, in September 2021, Livac USA, Inc. launched LiVac Retractor in the United States. The LiVac Retractor is a gentle, non-metal retractor that simplifies robotic and laparoscopic procedures and saves time for physicians while improving the recovery process and reducing the reliance on opioids for patients. It is the only retractor that retracts the upper surface of the liver. Thus, the above factors are expected to hold the region in the dominant position.
COVID-19 Impact Analysis
COVID-19 has impacted the minimally invasive surgical devices market. This is due to the reduced number of procedures and the declined number of individuals approaching doctors which has reduced the demand for the devices drastically. The medical device manufacturing units have been shut down for several days which has shortened the availability of the devices. The supply chain has been disrupted due to the pandemic. Thus, COVID-19 has impacted the market growth.
Market Segmentation
By Device Type
- Endoscopes
- Imaging equipments
- Endovascular catheters
- Trocars
- Insufflators
- Balloons
- Others
By Application
- Aesthetic
- Cardiovascular
- Gastrointestinal
- Gynecological
- Orthopedic
- Urological
- Other
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Competitive Landscape
The major global players in the market include Medtronic Plc, Nissha Medical Technologies, Ensinger Group, Karl Storz SE & Co. KG, Abbott Laboratories Inc., Fujifilm Holdings Corporation, KLS Martin Group, Trokamed GmbH, Symmetry Surgical Inc., and B. Braun Melsungen AG among others.
Why Purchase the Report?
- To visualize the global minimally invasive surgery devices market segmentation based on device type, application, end-user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of minimally invasive surgery devices market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global minimally invasive surgery devices market report would provide approximately 53 tables, 47 figures and 176 pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Device Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing launches of advanced minimally invasive surgery devices
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High costs of minimally invasive surgery devices
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Device Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
7.1.2. Market Attractiveness Index, By Device Type
7.2. Endoscopes*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Imaging equipment
7.4. Endovascular catheters
7.5. Trocars
7.6. Insufflators
7.7. Balloons
7.8. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Aesthetic*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cardiovascular
8.4. Gastrointestinal
8.5. Gynecological
8.6. Orthopedic
8.7. Urological
8.8. Other
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgical Centers
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.3.1. U.S.
10.2.3.2. Canada
10.2.3.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.4.1. Germany
10.3.4.2. UK
10.3.4.3. France
10.3.4.4. Italy
10.3.4.5. Spain
10.3.4.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.4.1. Brazil
10.4.4.2. Argentina
10.4.4.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.4.1. China
10.5.4.2. India
10.5.4.3. Japan
10.5.4.4. Australia
10.5.4.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Medtronic Plc*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Labcor Laboratórios Ltd
12.3. Braile Biomédica
12.4. CARDION s.r.o
12.5. Edwards Lifesciences Corporation
12.6. Abbott Laboratories Inc.
12.7. Corcym UK Limited
12.8. FOC Medical SA
12.9. Genesee BioMedical Inc.
12.10. DCD PRODUCTS SRL
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us